CIK 0001671927 · Large accelerated filer
Immunocore Holdings plc
Sign in to watch- Ticker
- IMCR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 01235 5430281
- Business address
- 90 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom, OX14 4RY
- Former names
- Immunocore Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-24 | Berman David M HEAD OF R&D | Sale 10b5-1 | −100 | $40.00 | $4K | 0 |
| 2025-11-24 | Berman David M HEAD OF R&D | Option exercise · Employee Share Option (Right to Buy) 10b5-1 | −100 | 136,690 | ||
| 2025-09-30 | Berman David M HEAD OF R&D | Option exercise 10b5-1 | +61,849 | $17.46 | $1.1M | 61,849 |
| 2025-09-30 | Berman David M HEAD OF R&D | Sale 10b5-1 | −61,849 | $35.23 | $2.2M | 0 |
| 2025-09-30 | Berman David M HEAD OF R&D | Option exercise · Employee Share Option (Right to Buy) 10b5-1 | −61,849 | 136,790 | ||
| 2025-09-15 | Berman David M HEAD OF R&D | Option exercise 10b5-1 | +200 | $17.46 | $3K | 200 |
| 2025-09-15 | Berman David M HEAD OF R&D | Sale 10b5-1 | −200 | $35.01 | $7K | 0 |
| 2025-09-15 | Berman David M HEAD OF R&D | Option exercise · Employee Share Option (Right to Buy) 10b5-1 | −200 | 198,639 | ||
| 2025-09-12 | Berman David M HEAD OF R&D | Option exercise 10b5-1 | +22,532 | $17.46 | $393K | 22,532 |
| 2025-09-12 | Berman David M HEAD OF R&D | Sale 10b5-1 | −21,232 | $35.63 | $756K | 1,300 |
| 2025-09-12 | Berman David M HEAD OF R&D | Sale 10b5-1 | −1,300 | $36.31 | $47K | 0 |
| 2025-09-12 | Berman David M HEAD OF R&D | Option exercise · Employee Share Option (Right to Buy) 10b5-1 | −22,532 | 198,839 | ||
| 2025-09-11 | Berman David M HEAD OF R&D | Option exercise 10b5-1 | +19,081 | $17.46 | $333K | 19,081 |
| 2025-09-11 | Berman David M HEAD OF R&D | Sale 10b5-1 | −19,081 | $36.28 | $692K | 0 |
| 2025-09-11 | Berman David M HEAD OF R&D | Option exercise · Employee Share Option (Right to Buy) 10b5-1 | −19,081 | 221,371 | ||
| 2025-09-10 | Berman David M HEAD OF R&D | Option exercise 10b5-1 | +31,338 | $17.46 | $547K | 31,338 |
| 2025-09-10 | Berman David M HEAD OF R&D | Sale 10b5-1 | −30,138 | $36.12 | $1.1M | 1,200 |
| 2025-09-10 | Berman David M HEAD OF R&D | Sale 10b5-1 | −1,200 | $36.77 | $44K | 0 |
| 2025-09-10 | Berman David M HEAD OF R&D | Option exercise · Employee Share Option (Right to Buy) 10b5-1 | −31,338 | 240,452 | ||
| 2025-05-15 | Ratcliffe Peter John Director | Grant or award · Share Option (Right to Buy) | +26,198 | 26,198 |
Page 3 of 6 · 118 trades